About
Viktor Roschke, PhD, is publicly listed by Neuraly as a co-founder and advisor. Neuraly is a clinical-stage biotechnology company developing therapies for Parkinson's disease, Alzheimer's disease, and related neurodegenerative disorders. No public evidence was found that Roschke operates an investment fund or deploys personal capital as an angel or family-office principal.
Areas of interest
biotechneurodegenerationParkinson's diseaseAlzheimer's diseasefibrosisdrug developmenttranslational medicineneuroinflammation